Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Inna, Sareneva"'
Autor:
Sandra Nance, Vered Yahalom, Nicole Thornton, Erwin A. Scharberg, Christine Lomas-Francis, Inna Sareneva
Publikováno v:
Vox Sanguinis. 110:209-218
International rare blood donor panels or registries are important in the consistent availability of rare blood for patients who need this scarce resource. In countries where it has been possible to commit resources to this effort and often where the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f6a833cd4dce91a3ee65b683e7c8d87
https://doi.org/10.1111/vox.12357
https://doi.org/10.1111/vox.12357
Autor:
Inna Sareneva, Susanna Sainio, Vedran Stefanovic, Kati Sulin, Malla Kuosmanen, Katri Haimila, Riina M. Jernman, Anu Korhonen
Publikováno v:
Immunohematology. 31:123-127
Anti-G is commonly present with anti-D and/or anti-C and can confuse serological investigations. In general, anti-G is not considered a likely cause of severe hemolytic disease of the fetus and newborn (HDFN), but it is important to differentiate it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9110daaa77fbb2ba4bb0ce5ce8e6c780
https://doi.org/10.21307/immunohematology-2019-080
https://doi.org/10.21307/immunohematology-2019-080
Autor:
Malla Kuosmanen, Suvi Natunen, Kati Sulin, Anu Korhonen, Jarno Tuimala, Inna Sareneva, Susanna Sainio, Katri Haimila
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 96(10)
Introduction The aim of this study was to assess the accuracy of the non-invasive fetal RHD test at 24-26 weeks of gestation as part of the national antenatal screening programme to target routine antenatal anti-D prophylaxis (RAADP) at 28-30 weeks a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93adfcc91f6562a98b6223bf83bc5146
https://pubmed.ncbi.nlm.nih.gov/28718198
https://pubmed.ncbi.nlm.nih.gov/28718198
Autor:
Riina, Jernman, Vedran, Stefanovic, Anu, Korhonen, Katri, Haimila, Inna, Sareneva, Kati, Sulin, Malla, Kuosmanen, Susanna, Sainio
Publikováno v:
Immunohematology. 31(3)
Anti-G is commonly present with anti-D and/or anti-C and can confuse serological investigations. in general, anti-G is not considered a likely cause of severe hemolytic disease of the fetus and newborn (HDFN), but it is important to differentiate it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::743a7eff600bb22b7841a24cda65c0ce
https://pubmed.ncbi.nlm.nih.gov/26829179
https://pubmed.ncbi.nlm.nih.gov/26829179
Autor:
Susanna Sainio, Katri Haimila, Jukka Uotila, Riina M. Jernman, Anu Korhonen, Malla Kuosmanen, Kati Sulin, Inna Sareneva
Publikováno v:
Gynecology & Obstetrics Case report.
Background: Ula, part of the Kell blood group system, is a low-frequency antigen found predominantly in the Finnish population. Anti-Ula is a rare antibody to cause hemolytic disease of the fetus and newborn (HDFN). Methods and Findings: We report on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95f78bfeb94306047e79df0fa8a9c99e
https://doi.org/10.21767/2471-8165.1000023
https://doi.org/10.21767/2471-8165.1000023
Autor:
Michael Pawlita, Lennart Kjellberg, Markus Schmitt, Göran Hallmans, Katri Haimila, Kari Hemminki, Rajesh Kumar, Asta Försti, Justo Lorenzo, Matti Lehtinen, Felipe A. Castro, Nelli Kunkel, Inna Sareneva
Publikováno v:
International Journal of Cancer. 125:1851-1858
High-risk human papillomavirus (hrHPV) infection is the major risk factor for cervical cancer (CxCa). The role of genetic susceptibility in the disease has been suggested, but the existing data lack consistency. We conducted a nested case-control stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::951ea93e385587c56fcc7244ec080450
https://doi.org/10.1002/ijc.24529
https://doi.org/10.1002/ijc.24529
Autor:
Inna, Sareneva, Susanne, Ekblom-Kuliberg, Katri, Haimila, Anu, Korhonen, Susanna, Sainio, Eeva, Juvonen
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 131(13-14)
A rare blood group and the associated anti-red cell antibody against a very common blood group factor make it significantly more difficult to find suitable red cell products, possibly endangering the additional treatment of the patient. The need of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db2f971c792203cab7791e433978d848
https://pubmed.ncbi.nlm.nih.gov/26536721
https://pubmed.ncbi.nlm.nih.gov/26536721
Publikováno v:
Blood. 122:4823-4823
The Finnish Red Cross Blood Service performs blood grouping of all blood donations in Finland and serves as a national reference laboratory in pre-transfusion testing of patients. In addition to ABO and RhD blood groups, other Rh antigens and K antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fa1b4bfbf2e76c9e9560ce21ca87dcd
https://doi.org/10.1182/blood.v122.21.4823.4823
https://doi.org/10.1182/blood.v122.21.4823.4823